Angiodynamics (ANGO) Shares Outstanding (2011 - 2026)

Angiodynamics (ANGO) has 16 years of Shares Outstanding data on file, last reported at $42.3 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding fell 99.9% year-over-year to $42.3 million; the trailing twelve-month figure through Feb 2026 stood at $42.3 million (down 99.9% YoY), and the FY2025 full-year result was $41.6 million, down 99.9% from the prior year.
• Shares Outstanding for Q1 2026 stood at $42.3 million, roughly flat from $42.2 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $41.6 billion in Q1 2025 and bottomed at $39.5 million in Q2 2022.
• The 5-year median for Shares Outstanding is $39.9 billion (2022), against an average of $26.3 billion.
• The widest annual swing landed in 2024, when Shares Outstanding soared 101951.39%; it then slumped 99.9% in 2025.
• A 5-year view of Shares Outstanding shows it stood at $39.9 billion in 2022, then advanced by 1.81% to $40.6 billion in 2023, then rose by 2.11% to $41.4 billion in 2024, then sank by 99.9% to $42.2 million in 2025, then increased by 0.26% to $42.3 million in 2026.
• The last three Shares Outstanding figures came in at $42.3 million (Q1 2026), $42.2 million (Q4 2025), and $42.1 million (Q3 2025), per Business Quant data.

Peer Comparison